G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $115,000 | -29.9% | 15,188 | -5.6% | 0.05% | -17.7% |
Q4 2021 | $164,000 | +31.2% | 16,088 | +72.2% | 0.06% | +12.7% |
Q3 2021 | $125,000 | -42.1% | 9,343 | -5.0% | 0.06% | -38.2% |
Q2 2021 | $216,000 | -41.5% | 9,832 | -35.8% | 0.09% | -42.9% |
Q1 2021 | $369,000 | +36.2% | 15,319 | +1.8% | 0.16% | +39.3% |
Q4 2020 | $271,000 | +40.4% | 15,055 | -9.9% | 0.11% | +10.9% |
Q3 2020 | $193,000 | -58.1% | 16,713 | -12.0% | 0.10% | -53.7% |
Q2 2020 | $461,000 | +188.1% | 18,991 | +30.4% | 0.22% | +230.3% |
Q1 2020 | $160,000 | -63.7% | 14,563 | -12.7% | 0.07% | -8.3% |
Q4 2019 | $441,000 | +42.3% | 16,684 | +22.6% | 0.07% | +16.1% |
Q3 2019 | $310,000 | -29.5% | 13,603 | -5.3% | 0.06% | -33.3% |
Q2 2019 | $440,000 | +205.6% | 14,360 | +65.9% | 0.09% | -69.6% |
Q1 2019 | $144,000 | -24.6% | 8,654 | -13.1% | 0.31% | +827.3% |
Q4 2018 | $191,000 | -65.4% | 9,954 | -5.7% | 0.03% | -42.1% |
Q3 2018 | $552,000 | -29.9% | 10,561 | -41.7% | 0.06% | -91.8% |
Q2 2018 | $787,000 | -44.3% | 18,103 | -52.5% | 0.70% | -43.2% |
Q1 2018 | $1,413,000 | +303.7% | 38,125 | +116.0% | 1.23% | +179.3% |
Q4 2017 | $350,000 | – | 17,647 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
RA Capital Management | 363,051 | $6,027,000 | 0.26% |
BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |